438 In vivo Engineered CAR-T cells for oncology using a surface-engineered lentivirus platform: nonclinical safety and biodistribution
Alissa Brandes(Unknown), Ryan Larson(CTI BioPharma (United States)), Christopher J. Nicolai(Metis Design Corporation (United States)), Anai M. Perez(Fred Hutch Cancer Center), Soo Min Koo, Rich Getto(CTI BioPharma (United States)), Byoung Y. Ryu(CTI BioPharma (United States)), Alyssa Sheih(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sarah Gould(Array BioPharma (United States)), Andrew M. Scharenberg(CTI BioPharma (Italy)), Kathryn Michels(CTI BioPharma (United States)), Susana Hernández, Nanda Coelho, Anna Ting, Alessandra M. Sullivan(CTI BioPharma (United States)), Mason Muhonen(Array BioPharma (United States)), Jeff Teoh, Jessica Freeman(Array BioPharma (United States))
Cited by 1
Related Papers
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897
TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization
|Cell|2002|751
A Unified Nomenclature for the Superfamily of TRP Cation Channels
|Molecular Cell|2002|679